WISDOM. Will Australian women participate?
OBJECTIVE
This study investigated the likelihood of 50-69 year old women participating in the Women's International Study of long Duration Oestrogen after Menopause (WISDOM)--a 10 year randomised placebo controlled trial of hormone replacement therapy involving 10 years treatment plus a further 10 years follow up of major health outcomes.


METHODS
The Health Monitor 2 (a representative population telephone survey) was used. Participants were 268 women aged 50-69 years from a total survey population of 2003 adults. Sociodemographic characteristics were collected.


RESULTS
Of the women surveyed 20.9% indicated they were likely to participate and this was independent of sociodemographic characteristics and self reported health status. Women aged 50-54 were more likely to participate than older women.


CONCLUSIONS
After allowing for exclusion criteria, it is estimated that approximately 10% of 50-69 year old women approached for recruitment in WISDOM may actually participate. There are likely to be sufficient altruistic women in this population to run WISDOM in Australia.
MacLennan
A H
AH
Department of Obstetrics and Gynaecology, University of Adelaide, South Australia.
Paine
B J
BJ
Marley
J E
JE
D000368:Aged; D001315:Australia; D003625:Data Collection; D003710:Demography; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D008593:Menopause; D008875:Middle Aged; D010358:Patient Participation; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012959:Socioeconomic Factors
D010919:Placebos